AstraZeneca subsidiary MedImmune Inc opened a new biologics research and development centre in Cambridge, UK, a major expansion to its base at the former Cambridge Antibody Technology facility.
They both come armed with broad plans to stimulate innovation, but the U.S. presidential hopefuls may face their own funding gap amid the flailing economy.
Researchers have established the International Human Microbiome Consortium to help further our understanding of the role of microbes in health and disease.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.